These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 27124395)
1. Molecular Predictors of Long-Term Survival in Glioblastoma Multiforme Patients. Lu J; Cowperthwaite MC; Burnett MG; Shpak M PLoS One; 2016; 11(4):e0154313. PubMed ID: 27124395 [TBL] [Abstract][Full Text] [Related]
2. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients. Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive molecular characterization of long-term glioblastoma survivors. Xu H; Chen X; Sun Y; Hu X; Zhang X; Wang Y; Tang Q; Zhu Q; Song K; Chen H; Sheng X; Yao Y; Zhuang D; Chen L; Mao Y; Qin Z Cancer Lett; 2024 Jul; 593():216938. PubMed ID: 38734160 [TBL] [Abstract][Full Text] [Related]
11. Increased expression of thymidylate synthetase (TS), ubiquitin specific protease 10 (USP10) and survivin is associated with poor survival in glioblastoma multiforme (GBM). Grunda JM; Nabors LB; Palmer CA; Chhieng DC; Steg A; Mikkelsen T; Diasio RB; Zhang K; Allison D; Grizzle WE; Wang W; Gillespie GY; Johnson MR J Neurooncol; 2006 Dec; 80(3):261-74. PubMed ID: 16773218 [TBL] [Abstract][Full Text] [Related]
12. A 4-miRNAs signature predicts survival in glioblastoma multiforme patients. Yuan GQ; Wei NL; Mu LY; Wang XQ; Zhang YN; Zhou WN; Pan YW Cancer Biomark; 2017 Dec; 20(4):443-452. PubMed ID: 28869437 [TBL] [Abstract][Full Text] [Related]
13. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes. Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456 [TBL] [Abstract][Full Text] [Related]
14. Glioblastoma multiforme with long term survival. Deb P; Sharma MC; Mahapatra AK; Agarwal D; Sarkar C Neurol India; 2005 Sep; 53(3):329-32. PubMed ID: 16230803 [TBL] [Abstract][Full Text] [Related]
15. A novel approach to the discovery of survival biomarkers in glioblastoma using a joint analysis of DNA methylation and gene expression. Smith AA; Huang YT; Eliot M; Houseman EA; Marsit CJ; Wiencke JK; Kelsey KT Epigenetics; 2014 Jun; 9(6):873-83. PubMed ID: 24670968 [TBL] [Abstract][Full Text] [Related]
16. Over ten years overall survival in glioblastoma: A different disease? Marton E; Giordan E; Siddi F; Curzi C; Canova G; Scarpa B; Guerriero A; Rossi S; D' Avella D; Longatti P; Feletti A J Neurol Sci; 2020 Jan; 408():116518. PubMed ID: 31715330 [TBL] [Abstract][Full Text] [Related]
17. DNA methylation profiles of long- and short-term glioblastoma survivors. Shinawi T; Hill VK; Krex D; Schackert G; Gentle D; Morris MR; Wei W; Cruickshank G; Maher ER; Latif F Epigenetics; 2013 Feb; 8(2):149-56. PubMed ID: 23291739 [TBL] [Abstract][Full Text] [Related]
18. Integrative analysis of DNA methylation and gene expression to identify key epigenetic genes in glioblastoma. Jia D; Lin W; Tang H; Cheng Y; Xu K; He Y; Geng W; Dai Q Aging (Albany NY); 2019 Aug; 11(15):5579-5592. PubMed ID: 31395792 [TBL] [Abstract][Full Text] [Related]
19. Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures. Yerukala Sathipati S; Huang HL; Ho SY BMC Genomics; 2016 Dec; 17(Suppl 13):1022. PubMed ID: 28155650 [TBL] [Abstract][Full Text] [Related]
20. Identification of potential biomarkers related to glioma survival by gene expression profile analysis. Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]